Stefanie Jaskulski

Stefanie Jaskulski

Auto-generated profile, based on publicly available information

Stefanie Jaskulski

Division of Cancer Epidemiology, German Cancer Research Center (DKFZ) , Heidelberg , Germany

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2019 in The American Journal of Clinical Nutrition
Verified
Journal Article
Closed access
AJAudrey Jung
Audrey Jung
XCXinting Cai
Xinting Cai
KTKathrin Thoene
Kathrin Thoene
NONadia Obi
Nadia Obi
SJStefanie Jaskulski
Stefanie Jaskulski
JCJenny Chang-Claude
Jenny Chang-Claude
There is a paucity of information on the prevalence of dietary supplement use in breast cancer survivors. Only a few studies have examined the impact of dietary supplements, particularly antioxidants, on breast cancer prognosis and the results are inconclusive. We examined pre- and postdiagnosis use of supplements in postmenopausal breast cancer survivors in Germany and investigated associations between postdiagnosis use of antioxidants and other supplements, and prognosis (total and breast cancer mortality, and recurrence-free survival) both overall and in women who received chemotherapy and radiation therapy. Data from 2223 postmenopausal women diagnosed with nonmetastatic breast cancer from the population-based Mamma Carcinoma Risk Factor Investigation (MARIE) study were used. Women were interviewed at recruitment in 2002-2005 and again in 2009 and followed-up until 30 June 2015. Multivariate Cox regression analysis was used to estimate HRs and corresponding 95% CIs. Pre- and postdiagnosis supplement use was reported by 36% and 45% of the women, respectively. There were 240 deaths (134 from breast cancer) and 200 breast cancer recurrences after a median follow-up time of 6.0 y after the 2009 re-interview. After adjusting for relevant confounders, concurrent antioxidant use with chemotherapy or radiation therapy among 1940 women was associated with increased risk of total mortality (HR: 1.64; 95% CI: 1.01, 2.66) and worsened recurrence-free survival (HR: 1.84; 95% CI: 1.26, 2.68). Overall postdiagnosis supplement use was not associated with breast cancer prognosis. Antioxidant use during chemotherapy or radiation therapy was associated with worsened breast cancer prognosis in postmenopausal women. There was no overall association between postdiagnosis supplement use and breast cancer prognosis. Results from our study align with the current recommendation to possibly avoid the use of antioxidants during chemotherapy or radiation therapy.

4 July 2018 in International Journal of Cancer
Verified
Journal Article
Closed access
PDF file
SJStefanie Jaskulski
Stefanie Jaskulski
AJAudrey Jung
Audrey Jung
SBSabine Behrens
Sabine Behrens
TJTheron Johnson
Theron Johnson
RKRudolf Kaaks
Rudolf Kaaks
JCJenny Chang-Claude
Jenny Chang-Claude

1 September 2017 in Molecular Nutrition & Food Research
Verified
Journal Article
Closed access
PDF file
SJStefanie Jaskulski
Stefanie Jaskulski
AJAudrey Jung
Audrey Jung
ARAnja Rudolph
Anja Rudolph
TJTheron Johnson
Theron Johnson
KTKathrin Thöne
Kathrin Thöne
JCJenny Chang-Claude
Jenny Chang-Claude

2 October 2019 in Nutrition and Cancer
Verified
Journal Article
Closed access
SJStefanie Jaskulski
Stefanie Jaskulski
AJAudrey Jung
Audrey Jung
Marianne HuebnerMarianne Huebner
Marianne Huebner
GPGernot Poschet
Gernot Poschet
RHRüdiger Hell
Rüdiger Hell
JCJenny Chang-Claude
Jenny Chang-Claude
Lignans are associated with improved postmenopausal breast cancer (BC) survival, but whether these associations, particularly with enterolactone (major lignan metabolite), persist over time is unclear. Little is known about other phytoestrogens on prognosis in long-term survivors. The study examines associations of prognosis with 1) circulating postdiagnosis enterolactone, 2) eight circulating phytoestrogen metabolites, and 3) changes in enterolactone and genistein. In a German cohort of 2,105 postmenopausal BC patients with blood samples collected at recruitment 2002–2005 (baseline) and re-interview in 2009 (follow-up), delay-entry Cox proportional hazards regression was used. Landmark analysis showed that circulating enterolactone (log2) associations with 5-year survival changed over time, with strongest hazard ratios of 0.89 (95% CI, 0.80–0.99) at blood draw (BD) and 0.86 (0.77–0.97) at 2 years post-BD for BC mortality, and 0.87 (0.80–0.95) at BD and 0.84 (0.76–0.92) at 3 years post-BD for all-cause mortality, which attenuated thereafter. In long-term survivors, increasing concentrations of genistein (1.17, 1.01–1.36), resveratrol (1.19, 1.02–1.40), and luteolin (1.96, 1.07–3.58) measured in follow-up blood samples were associated with poorer subsequent prognosis. Neither enterolactone at follow-up nor changes in enterolactone/genistein were associated with prognosis. Large long-term longitudinal studies with multiple phytoestrogen measurements are required to understand long-term effects of phytoestrogens after BC.

27 February 2026 in Journal of Migration and Health
Verified
Journal Article
Open access
DODaniëlle Otten
Daniëlle Otten
CKC. Kasinger
C. Kasinger
LKL. Kriechel
L. Kriechel
ATA.N. Tibubos
A.N. Tibubos
KBK. Berger
K. Berger
KWKerstin Wirkner
Kerstin Wirkner
• Internal German migrants differ from each other regarding sociodemography. • Differences between internal migrant groups regarding mental health are negligible. • Substantial heterogeneity within migration groups may dilute average differences. • Internal migration alone no substantial factor in explaining mental health differences. • Alignment regarding mental health between East- and West Germany.